Thomas Myers
Sports Medicine · Atlanta, GANPI 1255375820
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $62,842 of the $71,948 with a category attached, or 87.3%. DJO, LLC accounts for 87.3% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $17,130 and has fallen 56.6% since, to $7,432 in 2025. Among sports medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $757.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- DJO, LLC$63K
- International Life Sciences$3K
- Moximed, Inc$1K
- Stryker$837
- Encore Medical, LP$752
- Arthrex$642
- plus $2K from 24 others
What the payments were for
- Royalty or licence$62,84287%
- Consulting fees$4,9807%
- Travel & lodging$1,9433%
- Food & beverage$2,1843%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| DJO, LLC | 27 | $62,842 |
| International Life Sciences | 2 | $3,000 |
| Moximed, Inc | 7 | $1,391 |
| Stryker | 7 | $837 |
| Encore Medical, LP | 2 | $752 |
| Arthrex | 11 | $642 |
| Medacta USA, Inc. | 5 | $590 |
| Miach Orthopaedics, Inc. | 2 | $522 |
| United Orthopedics LLC | 3 | $488 |
| Smith+Nephew | 6 | $329 |
| Medical Device Business Services, Inc. | 1 | $87 |
| Galt Pharmaceuticals, LLC | 1 | $64 |
| Tenex Health Inc. | 1 | $58 |
| Johnson & Johnson | 2 | $52 |
| Molnlycke Health Care US, LLC | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Zyla Life Sciences, Inc. | 2 | $32 |
| Heraeus Medical, LLC. | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Davol Inc. | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Next Science LLC | 1 | $16 |
| Medtronic | 1 | $16 |
| Amgen | 1 | $13 |
| Anika Therapeutics, Inc. | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $12 |
| Bioventus LLC | 1 | $12 |
| Think Surgical, Inc. | 1 | $11 |
| Orthofix Medical, Inc. | 1 | $10 |
| ERMI LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$71,948 in reported general payments places this provider in the 95th percentile of 168 sports medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 20 | $28 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Atlanta
- John XerogeanesAtlanta$4M
- Spero KarasAtlanta$137K
- Xavier DuraldeAtlanta$77K
- Phillip LangerAtlanta$33K
- Richard DanilkowiczAtlanta$32K
- Austin LooneyAtlanta$29K
- James KercherAtlanta$24K
- Kyle HammondAtlanta$18K
- Charles GartenAtlanta$16K
- John KoprivaAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.